About the Ontario-Israel Collaboration Program
In April 2005, the Government of Ontario and the Government of the State of Israel signed a Memorandum of Understanding (MOU) on Industrial and Technological Research and Development Cooperation. Under this agreement, the two governments have committed to strengthen and promote industrial partnerships and project collaborations that are of mutual interest to Ontario and Israeli companies. The Ontario-Israel Collaboration Program was established to further the objectives of this MOU. This program is managed by the Ministry of Economic Development and Innovation and provides early stage investment for bilateral R&D initiatives by contributing up to 50 percent of joint project costs, to a maximum of $300,000.
Canada-Israel Industrial R&D Foundation and the Ontario Brain Institute, together with partners in Israel, have created a collaboration to develop and commercialize novel neurotechnologies. The emerging bilateral partnerships are propelling the development of groundbreaking diagnostics and treatments for brain conditions such as Attention-Deficit Hyperactivity Disorder, Multiple Sclerosis, Depression, Stroke, Autism, Alzheimer’s and Parkinson’s Diseases. These jointly developed innovations could improve the quality of life for the hundreds of millions of people affected by these conditions, and help innovators to capitalize on the $23 billion global neuro-device and diagnostics market.